ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
88,500
+3,800 (4.49%)
Jul 31, 2026, 3:30 PM KST

ST Pharm Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
69,01154,99234,71219,58118,0003,312
Depreciation & Amortization
31,82229,88125,58223,02717,60014,414
Loss (Gain) From Sale of Assets
315.28328.521,6920.62515.432,543
Asset Writedown & Restructuring Costs
-32-60.5-47.79---
Loss (Gain) From Sale of Investments
-6,281-6,870-12,3908,063628.83-147.24
Stock-Based Compensation
1,8421,5423,2465,2985,0192,116
Provision & Write-off of Bad Debts
1,8871,7153.87188.27-0.06-138.94
Other Operating Activities
16,34711,84319,9489,9206,0886,619
Change in Accounts Receivable
17,361-30,52953,012-25,749-47,568-6,471
Change in Inventory
-59,049-52,821-12,944-13,226-25,939-37,301
Change in Accounts Payable
1,7681,295-7,321-369.936,0718,169
Change in Other Net Operating Assets
24,7302,6743,958-25,43526,61514,154
Operating Cash Flow
99,72313,989109,4511,2987,0317,270
Operating Cash Flow Growth
11.44%-87.22%8329.82%-81.53%-3.29%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-35,257-47,072-82,806-43,244-60,479-51,792
Sale of Property, Plant & Equipment
48.8351.6168.5100.943.67612.72
Sale (Purchase) of Intangibles
-207.61-213.64-238.11-198.7108.52-125.09
Investment in Securities
32,48817,089-8,021-40,70854,08542,492
Other Investing Activities
3,2433,8194,3541,662557.09779.23
Investing Cash Flow
315.53-26,326-86,543-82,388-5,724-8,034

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-11,47925,00025,87820,000-
Long-Term Debt Issued
--190.16101,45416,500-
Total Debt Issued
11,76611,47925,190127,33236,500-
Short-Term Debt Repaid
----33,333--
Long-Term Debt Repaid
--20,900-25,890-1,861-16,750-1,019
Total Debt Repaid
-18,821-20,900-25,890-35,195-16,750-1,019
Net Debt Issued (Repaid)
-7,054-9,421-699.6892,13719,750-1,019
Issuance of Common Stock
4,392-----
Dividends Paid
-10,076-10,076-9,404-9,404-9,404-
Other Financing Activities
-759.56-585.48-849.82-1,331462.3903.14
Financing Cash Flow
-13,498-20,083-10,95481,40110,808-115.59

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-42.15-439.641,353-415.46-1,1171,457
Net Cash Flow
86,498-32,85913,308-103.9110,998578.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
64,466-33,08226,646-41,946-53,448-44,522
Free Cash Flow Growth
------
Free Cash Flow Margin
18.62%-9.97%9.73%-14.72%-21.44%-26.88%
Free Cash Flow Per Share
2979.58-1542.641366.16-2230.12-2841.64-2385.36
Levered Free Cash Flow
57,019-31,05710,548-58,932-68,609-73,918
Unlevered Free Cash Flow
59,542-28,53415,384-55,116-66,817-70,695

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
747.38578.08817.461,331929.58447.67
Cash Income Tax Paid
5,4068,7424,9552,1182,868-826.64
Change in Working Capital
-15,189-79,38136,705-64,780-40,821-21,449